Open company graph database — free web & API
ログイン

Ferring Pharmaceuticals

Ferring Canada別名フェリング製薬別名
銘柄コード
—
上場市場
—
国
Canada
従業員(単独)
—
関連会社
0
§01

基本情報

BASIC
所在地
Toronto, Canada出典
社長
出典
従業員数(単独)
従業員数(連結)
開始日
終了日
§02

サイト

1 DOMAINS
§03

事業内容

9
Reproductive Medicine出典出典Urology出典出典Gastroenterology出典出典research出典development出典marketing of innovative treatments出典patient assistance programs出典Ferring Connect出典Patient Assistance Programs出典
§04

関連会社

0 COMPANIES

—

§05

関連図

NETWORK
ドラッグで移動 · クリックで詳細へ
§07

ニュース

4 ARTICLES

Ferring partners for Bladder Cancer出典

Ferring Pharmaceuticals announced its partnership with community organizations to support Bladder Cancer Awareness Month 2025. The initiative aims to improve early detection and patient outcomes by raising awareness of symptoms such as blood in urine and painful urination. The company emphasizes the need for timely medical attention to reduce delayed diagnoses and improve prognosis.

Ferring Secures Canada Approval REBYOTA出典

Ferring Inc. announced that Health Canada has issued a Notice of Compliance approving REBYOTA®, a first‑in‑class microbiome‑restoration therapy for preventing recurrence of Clostridioides difficile infection in adults. The approval follows antibiotic treatment for recurrent C. diff.

Ferring Canada Report for Bill S-211出典

Ferring Canada Report for Bill S-211

Ferring grants target health inequalities出典

Ferring Pharmaceuticals announced 17 winners of a grant programme addressing inequalities in reproductive medicine and maternal health. Projects include research into declining modern sperm counts and support for safer births in rural Ethiopia through trained midwives and solar power kits.

§09

出典・更新

SOURCES
↑